CSPC Pharmaceutical Group Ltd (CSPCY)
3.17
-0.05
(-1.55%)
USD |
OTCM |
Jun 21, 16:00
CSPC Pharmaceutical Group Price to Book Value: 2.013 for June 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 21, 2024 | 2.013 |
| June 20, 2024 | 2.044 |
| June 18, 2024 | 2.127 |
| June 17, 2024 | 2.143 |
| June 14, 2024 | 2.168 |
| June 13, 2024 | 2.194 |
| June 12, 2024 | 2.182 |
| June 11, 2024 | 2.20 |
| June 10, 2024 | 2.210 |
| June 07, 2024 | 2.210 |
| June 06, 2024 | 2.222 |
| June 05, 2024 | 2.202 |
| June 04, 2024 | 2.216 |
| June 03, 2024 | 2.114 |
| May 31, 2024 | 2.178 |
| May 30, 2024 | 2.210 |
| May 29, 2024 | 2.152 |
| May 28, 2024 | 2.244 |
| May 24, 2024 | 2.057 |
| May 23, 2024 | 2.032 |
| May 22, 2024 | 2.064 |
| May 21, 2024 | 2.114 |
| May 20, 2024 | 2.152 |
| May 17, 2024 | 2.146 |
| May 16, 2024 | 2.178 |
| Date | Value |
|---|---|
| May 15, 2024 | 2.165 |
| May 14, 2024 | 2.156 |
| May 13, 2024 | 2.210 |
| May 10, 2024 | 2.203 |
| May 09, 2024 | 2.175 |
| May 08, 2024 | 2.146 |
| May 07, 2024 | 2.127 |
| May 06, 2024 | 2.171 |
| May 03, 2024 | 2.184 |
| May 02, 2024 | 2.181 |
| May 01, 2024 | 2.083 |
| April 30, 2024 | 2.057 |
| April 29, 2024 | 2.114 |
| April 26, 2024 | 2.109 |
| April 25, 2024 | 2.064 |
| April 24, 2024 | 1.962 |
| April 23, 2024 | 1.911 |
| April 22, 2024 | 1.905 |
| April 19, 2024 | 1.836 |
| April 18, 2024 | 1.856 |
| April 17, 2024 | 1.838 |
| April 16, 2024 | 1.845 |
| April 15, 2024 | 1.864 |
| April 12, 2024 | 1.868 |
| April 11, 2024 | 1.931 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.141
Minimum
Jul 22 2019
6.909
Maximum
Nov 14 2019
3.547
Average
3.256
Median
Mar 22 2022
Price to Book Value Benchmarks
| Sinovac Biotech Ltd | 0.074 |
| CASI Pharmaceuticals Inc | 3.206 |
| Zai Lab Ltd | 2.405 |
| Adagene Inc | 1.928 |
| LakeShore Biopharma Co Ltd | 0.7313 |
Price to Book Value Related Metrics
| PE Ratio | 11.33 |
| PS Ratio | 2.114 |
| Price | 3.17 |
| Earnings Yield | 8.83% |
| Market Cap | 9.428B |
| Operating PE Ratio | 9.484 |
| Normalized PE Ratio | 11.33 |